Metabolism
Encorium Reports 2007 Second Quarter Financial Results
Published in Drug Law Weekly, August 28th, 2007
Encorium Group, Inc. (Nasdaq: ENCO), a leader in the design, development, and management of complex clinical trials and patient registries for many of the world's leading pharmaceutical and biotechnology companies, announced its financial results for the second quarter ended June 30, 2007 (see attached tables). These financial results include a full quarter and six months of combined operations following the November 1, 2006 closing of Encorium's business combination with Remedium Oy, a privately owned, full-service contract research organization (CRO) based in Espoo, Finland.
Kenneth M. Borow, M.D., President and Chief Executive Officer for Encorium Group, commented,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2007-08-28)
More Articles from Drug Law Weekly
- Addiction Medicine
Online Tool Educates MySpace Generation about Opioid Addiction - Biomedicine
Gift to Technology Boosts Power for Gene Discovery - Biopharmaceuticals
Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA (Human TGF BETA 3) - Biopharmaceuticals
Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Northwest Biotherapeutics Inc. - Biotech Business
ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego - Cancer
Cytyc and Xoft Settle Intellectual Property Dispute - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
